The GHIT Fund is establishing a Drug Discovery Screening Platform to facilitate the screening of compound libraries for identification of novel compounds for malaria, tuberculosis, and neglected tropical diseases. The goal is to leverage the active screening programs of established Product Development Partnerships (PDPs) and the relevant compound libraries from Japanese companies or academic institutions.

The expectation is that the Japanese entity will provide its relevant compound libraries to their PDP partner, who will then conduct screening with support from their established screening organization network. The GHIT Fund will reimburse for screening project costs.

For more details, please go to "Funding Opportunies"